All News

The National Diabetes Statistics Report found that 1 in 4 patients are unaware they have diabetes.

Proper dosing of Vorinostat can help expose latent HIV.

When cancerous cells die, they instruct neighboring cells to replace them.

The FDA has granted tentative approval to Merck's Lusduna Nexvue (insulin glargine injection) 100 units/mL. The drug is a follow-on biologic basal insulin for patients with type 2 diabetes and is administered through a pre-filled dosing device, according to a press release.

Belimumab (Benlysta) in a subcutaneous treatment for active, autoantibody-positive systemic lupus erythematosus.

Memory T cell subtypes can be reactivated with current immunotherapy.

Subcutaneous belimumab (Benlysta) is a human monoclonal antibody that treats active, autoantibody-positive systemic lupus erythematosus.

Lusduna Nexvue insulin glargine injection is a follow-on biologic for patients with type 2 diabetes.

Sanofi lawsuit delays emergence of follow-on biologic of insulin glargine injection for type 2 diabetes.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Renflexis is indicated for the same inflammatory conditions as reference drug infliximab.

Renflexis is a biosimilar of Remicade, which treats inflammatory conditions, including Crohn’s disease, rheumatoid arthritis, and psoriatic arthritis.

Generic drug prescribing and use continues to trend upward in workers compensation, according to a report recently released by Coventry Workers Comp Services. Generic drug prescribing and use continues to trend upward in workers compensation, according to a report recently released by Coventry Workers Comp Services.

This article contains a great snapshot into U-500 education to further your knowledge and promote patient safety.

Pharmacists have a great responsibility to stay current with the laws and regulations governing the profession.

We will explore some common herbal remedies for hangover symptoms and consider the peer-reviewed evidence behind their use.

We spoke with him to find out how he got the idea for the site, how it works and what his plans are for the future.

Top articles of the week from The American Journal of Pharmacy Benefits.

Key aspect of NACDS Regulatory Reform Initiative will benefit patients and enhance use of e-prescribing to prevent drug abuse and diversion

Officials with GSK announced that the US FDA has approved a new subcutaneous formulation of belimumab (Benlysta) for the treatment of adult patients with active, autoantibody‑positive systemic lupus erythematosus (SLE) who are receiving standard therapy.

The National Diabetes Statistics Report, released approximately every 2 years, provides information on diabetes prevalence and incidence, prediabetes, risk factors for complications, acute and long-term complications, mortality, and costs in the United States.

A combination of doxorubicin plus an aldose reductase inhibitor prevented cardiotoxicity in patients with colon cancer.

Potential treatment for primary progressive multiple sclerosis is an oral pill consisting of pharmaceutical formulations of purified THC and CBD.

A diet enriched with extra-virgin olive oil observed to reduce amyloid plaque and phosphorylated tau in mice.

Enzyme acts as an epigenetic checkpoint of T cell function to treat cancer.

Drug combination expected to increase efficacy of pembrolizumab (Keytruda) in patients with non-small cell lung cancer.

Novel pathogen-associated molecular pattern drug combined with checkpoint inhibitor also evaluated in non small cell lung cancer.

Imaging technique detects inflammation that precedes cardiovascular disease and heart attacks.

Mice fed a diet enriched with red tomatoes observed to be less likely to develop skin cancer.